🔴 Nasus Pharma is trading 5.47% down today as Treasury yields reach a 19-year high

Nasus Pharma is trading at $3.45 (-5.47%) amid broad market pressure.

• Broader markets are under pressure as Treasury yields reach a 19-year high and oil exceeds $107
• The September 14 FDA clearance for NS002 remains the latest company-specific catalyst, supporting a planned pivotal study in Q4 2026
• Healthcare sector strength is not preventing this individual pullback after reversing part of the September 14 FDA-clearance rally